<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02846389</url>
  </required_header>
  <id_info>
    <org_study_id>Pro2016-0162</org_study_id>
    <nct_id>NCT02846389</nct_id>
  </id_info>
  <brief_title>Trial of Exercise to Reduce Cancer Related Fatigue in Breast Cancer</brief_title>
  <official_title>Randomized Controlled Trial of Exercise to Reduce Cancer Related Fatigue in Women Undergoing Radiation Treatment for Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hackensack University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lombardi Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hackensack University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Like other cancer treatments, radiation therapy can make people feel fatigued, or tired. The
      investigators think that moderate exercise, done 15 minutes at a time, can reduce the
      fatigue. This study is designed to gather more information, so that in the future, doctors
      can recommend whether patients should engage in exercise during a radiation treatment course.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cancer related fatigue (CRF) is a common and debilitating side effect of radiotherapy in
      breast cancer patients. Physical activity interventions can attenuate CRF. The proposed study
      is a randomized, controlled trial (RCT) of exercise of structured moderate-intensity exercise
      intervention, delivered concurrently with radiotherapy, to reduce CRF and improve
      health-related quality of life among breast cancer patients. Eighty women with breast cancer
      scheduled to receive radiation therapy at Hackensack University Medical Center (HUMC) will be
      randomized to one of the two trial arms:1) a facility-based aerobic exercise utilizing a
      portable stationary pedal exerciser; or 2) a control group. Intervention arm participants
      will exercise at the hospital either before or after their radiation treatment. Assessments
      will be conducted at baseline, 4 weeks into radiation course, and at 4-week follow-up visit.
      The outcome variables are CRF, biomarkers of inflammation, and health-related quality of life
      (QOL). The study will provide preliminary evidence on whether a short-term moderate-intensity
      exercise intervention might be effective in reducing CRF in women undergoing radiotherapy for
      breast cancer, and whether this effect is mediated by inflammation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 21, 2016</start_date>
  <completion_date type="Anticipated">May 2026</completion_date>
  <primary_completion_date type="Anticipated">May 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of change in fatigue via Functional Assessment of Chronic Illness Therapy (FACIT-Fatigue) survey instrument.</measure>
    <time_frame>Baseline, 4 weeks into RT, 4 week follow up visit</time_frame>
    <description>The FACIT is a 13-item subscale developed to identify a finite set of concerns specific to fatigue. The responses to the 13 items on the FACIT-Fatigue questionnaire are each measured on a 4-point likert scale, with score ranging from 0 to 52. The FACIT-Fatigue scale has been validated in patients with cancer and showed excellent internal consistency and reliability.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of change in blood biomarker of inflammation: High sensitivity CRP (hsCRP)</measure>
    <time_frame>Baseline, 4 weeks into RT, 4 week follow up visit</time_frame>
    <description>Serum hsCRP will be measured on the Vitros 5,1 FS Chemistry platform via an immunoassay with a reportable range of 0.10 -15.00 mg/L, and intra- and inter-assay CVs of 1.8-4.0%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of change in blood biomarker of inflammation: Serum fibrinogen</measure>
    <time_frame>Baseline, 4 weeks into RT, 4 week follow up visit</time_frame>
    <description>Fibrinogen will be measured using standardized clinical protocols. All assays have intra- and inter-assays coefficient of variations &lt;10%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Assessment of change in blood biomarker of inflammation: Ferritin</measure>
    <time_frame>Baseline, 4 weeks into RT, 4 week follow up visit</time_frame>
    <description>Ferritin will be measured using standardized clinical protocols. All assays have intra- and inter-assays coefficient of variations &lt;10%.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complete blood count data (CBC)</measure>
    <time_frame>Baseline, 4 weeks into RT, 4 week follow up visit</time_frame>
    <description>We will collect CBC data at each blood draw for correlative and explorative purposes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of change in Cancer-related healthcare quality of life (HRQOL) measured using the Functional Assessment of Cancer Therapy (FACT) system questionnaires.</measure>
    <time_frame>Baseline, 4 weeks into RT, 4 week follow up visit</time_frame>
    <description>The HRQOL measures four different domains (physical well-being, functional well-being, emotional well-being, and social/family well-being). FACT-B is a breast cancer specific module that will be used to reflect patients' concerns; moreover, they are reliable, reproducible, and have been validated in numerous studies.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cancer Related Fatigue</condition>
  <arm_group>
    <arm_group_label>Moderate Exercise</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Moderate exercise - 15 minutes a day using a pedal box before or after radiation at the hospital (75 minutes a week).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Moderate Exercise</intervention_name>
    <description>Aerobic training utilizing the portable stationary pedal exerciser (Pedlar) which contains two cycling pedals mounted to a stationary block that allows patients to exercise while sitting. Participants are required to perform 15 minutes/day of aerobic exercise using the Pedlar device on radiation treatment days; during a standard radiation course, this will typically yield 75 minutes/week of aerobic time.</description>
    <arm_group_label>Moderate Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. women between the ages of 18 and 75 years

          2. histologically confirmed non-metastatic carcinoma of the breast (in situ disease or
             invasive)

          3. radiation therapy na√Øve

          4. sedentary activity level at baseline, as defined by less than 60 minutes per week of
             modest physical activity based on 7-day physical activity recall questionnaire

          5. ambulatory

          6. negative serum pregnancy test and not planning to become pregnant in the next three
             months

          7. able to provide meaningful consent.

          8. Patients must have been deemed by their medical oncologist or internist that they &quot;may
             participate in [this] exercise trial.&quot; Prior to randomization, participants are
             required to complete a Physical Activity Readiness Questionnaire (PAR-Q) that includes
             questions regarding physical and medical conditions that would preclude safe
             participation in an exercise program.

        Exclusion Criteria:

          1. younger than 18 or older than 75 years

          2. no histological confirmation of breast cancer

          3. prior breast, chest, or pelvic radiotherapy

          4. concurrent chemotherapy

          5. distant metastases

          6. physical limitations that contraindicate participation in low to moderate intensity
             exercise

          7. positive pregnancy test

          8. currently engaged in moderate to vigorous physical activity

          9. psychiatric disorder which would render the participant unable to provide informed
             consent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Brett Lewis, M.D., Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hackensack UMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hackensack University Medical Center</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Trina McClendon</last_name>
      <phone>551-996-4063</phone>
      <email>Trina.Mcclendon@hackensackmeridian.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Potthoff K, Schmidt ME, Wiskemann J, Hof H, Klassen O, Habermann N, Beckhove P, Debus J, Ulrich CM, Steindorf K. Randomized controlled trial to evaluate the effects of progressive resistance training compared to progressive muscle relaxation in breast cancer patients undergoing adjuvant radiotherapy: the BEST study. BMC Cancer. 2013 Mar 28;13:162. doi: 10.1186/1471-2407-13-162.</citation>
    <PMID>23537231</PMID>
  </reference>
  <reference>
    <citation>Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med. 2002 Aug 22;347(8):567-75.</citation>
    <PMID>12192016</PMID>
  </reference>
  <reference>
    <citation>Zelefsky MJ, Fuks Z, Hunt M, Yamada Y, Marion C, Ling CC, Amols H, Venkatraman ES, Leibel SA. High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1111-6.</citation>
    <PMID>12128109</PMID>
  </reference>
  <reference>
    <citation>Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, Fisher ER, Wickerham DL, Deutsch M, Margolese R, Dimitrov N, Kavanah M. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998 Feb;16(2):441-52.</citation>
    <PMID>9469327</PMID>
  </reference>
  <reference>
    <citation>Bagshaw MA, Kaplan ID, Cox RC. Prostate cancer. Radiation therapy for localized disease. Cancer. 1993 Feb 1;71(3 Suppl):939-52. Review.</citation>
    <PMID>8428344</PMID>
  </reference>
  <reference>
    <citation>Alc√¢ntara-Silva TR, Freitas-Junior R, Freitas NM, Machado GD. Fatigue related to radiotherapy for breast and/or gynaecological cancer: a systematic review. J Clin Nurs. 2013 Oct;22(19-20):2679-86. doi: 10.1111/jocn.12236. Epub 2013 May 8. Review.</citation>
    <PMID>23651041</PMID>
  </reference>
  <reference>
    <citation>Steindorf K, Schmidt ME, Klassen O, Ulrich CM, Oelmann J, Habermann N, Beckhove P, Owen R, Debus J, Wiskemann J, Potthoff K. Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life. Ann Oncol. 2014 Nov;25(11):2237-43. doi: 10.1093/annonc/mdu374. Epub 2014 Aug 5.</citation>
    <PMID>25096607</PMID>
  </reference>
  <reference>
    <citation>Dhruva A, Dodd M, Paul SM, Cooper BA, Lee K, West C, Aouizerat BE, Swift PS, Wara W, Miaskowski C. Trajectories of fatigue in patients with breast cancer before, during, and after radiation therapy. Cancer Nurs. 2010 May-Jun;33(3):201-12. doi: 10.1097/NCC.0b013e3181c75f2a.</citation>
    <PMID>20357659</PMID>
  </reference>
  <reference>
    <citation>Jereczek-Fossa BA, Marsiglia HR, Orecchia R. Radiotherapy-related fatigue. Crit Rev Oncol Hematol. 2002 Mar;41(3):317-25. Review.</citation>
    <PMID>11880207</PMID>
  </reference>
  <reference>
    <citation>Morrow GR, Shelke AR, Roscoe JA, Hickok JT, Mustian K. Management of cancer-related fatigue. Cancer Invest. 2005;23(3):229-39. Review.</citation>
    <PMID>15945509</PMID>
  </reference>
  <reference>
    <citation>Mustian KM, Peppone L, Darling TV, Palesh O, Heckler CE, Morrow GR. A 4-week home-based aerobic and resistance exercise program during radiation therapy: a pilot randomized clinical trial. J Support Oncol. 2009 Sep-Oct;7(5):158-67.</citation>
    <PMID>19831159</PMID>
  </reference>
  <reference>
    <citation>Noal S, Levy C, Hardouin A, Rieux C, Heutte N, S√©gura C, Collet F, Allouache D, Switsers O, Delcambre C, Delozier T, Henry-Amar M, Joly F. One-year longitudinal study of fatigue, cognitive functions, and quality of life after adjuvant radiotherapy for breast cancer. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):795-803. doi: 10.1016/j.ijrobp.2010.06.037. Epub 2010 Oct 1.</citation>
    <PMID>20888704</PMID>
  </reference>
  <reference>
    <citation>Hickok JT, Roscoe JA, Morrow GR, Mustian K, Okunieff P, Bole CW. Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer. Cancer. 2005 Oct 15;104(8):1772-8.</citation>
    <PMID>16116608</PMID>
  </reference>
  <reference>
    <citation>Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. Mechanisms of cancer-related fatigue. Oncologist. 2007;12 Suppl 1:22-34. Review.</citation>
    <PMID>17573453</PMID>
  </reference>
  <reference>
    <citation>Bower JE, Ganz PA, Tao ML, Hu W, Belin TR, Sepah S, Cole S, Aziz N. Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer. Clin Cancer Res. 2009 Sep 1;15(17):5534-40. doi: 10.1158/1078-0432.CCR-08-2584. Epub 2009 Aug 25.</citation>
    <PMID>19706826</PMID>
  </reference>
  <reference>
    <citation>Geinitz H, Zimmermann FB, Stoll P, Thamm R, Kaffenberger W, Ansorg K, Keller M, Busch R, van Beuningen D, Molls M. Fatigue, serum cytokine levels, and blood cell counts during radiotherapy of patients with breast cancer. Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):691-8.</citation>
    <PMID>11597810</PMID>
  </reference>
  <reference>
    <citation>Lundh Hagelin C, Wengstr√∂m Y, F√ºrst CJ. Patterns of fatigue related to advanced disease and radiotherapy in patients with cancer-a comparative cross-sectional study of fatigue intensity and characteristics. Support Care Cancer. 2009 May;17(5):519-26. doi: 10.1007/s00520-008-0502-5. Epub 2008 Sep 13.</citation>
    <PMID>18791747</PMID>
  </reference>
  <reference>
    <citation>Hovdenak N, Fajardo LF, Hauer-Jensen M. Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1111-7.</citation>
    <PMID>11072170</PMID>
  </reference>
  <reference>
    <citation>Larsen A, Bj√∏rge B, Klementsen B, Helgeland L, Wentzel-Larsen T, Fagerhol MK, Hovdenak N, Dahl O. Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy. Acta Oncol. 2007;46(5):639-50.</citation>
    <PMID>17562440</PMID>
  </reference>
  <reference>
    <citation>Symon Z, Goldshmidt Y, Picard O, Yavzori M, Ben-Horin S, Alezra D, Barshack I, Chowers Y. A murine model for the study of molecular pathogenesis of radiation proctitis. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):242-50. doi: 10.1016/j.ijrobp.2009.07.1736.</citation>
    <PMID>20005457</PMID>
  </reference>
  <reference>
    <citation>Greenberg DB, Gray JL, Mannix CM, Eisenthal S, Carey M. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage. 1993 May;8(4):196-200.</citation>
    <PMID>7963760</PMID>
  </reference>
  <reference>
    <citation>Christiansen H, Saile B, Hermann RM, Rave-Fr√§nk M, Hille A, Schmidberger H, Hess CF, Ramadori G. Increase of hepcidin plasma and urine levels is associated with acute proctitis and changes in hemoglobin levels in primary radiotherapy for prostate cancer. J Cancer Res Clin Oncol. 2007 May;133(5):297-304. Epub 2006 Nov 25.</citation>
    <PMID>17393200</PMID>
  </reference>
  <reference>
    <citation>Saligan LN, Kim HS. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav Immun. 2012 Aug;26(6):830-48. doi: 10.1016/j.bbi.2012.05.004. Epub 2012 May 14. Review.</citation>
    <PMID>22595751</PMID>
  </reference>
  <reference>
    <citation>Courneya KS, Mackey JR, Bell GJ, Jones LW, Field CJ, Fairey AS. Randomized controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol. 2003 May 1;21(9):1660-8.</citation>
    <PMID>12721239</PMID>
  </reference>
  <reference>
    <citation>Cuesta-Vargas AI, Buchan J, Arroyo-Morales M. A multimodal physiotherapy programme plus deep water running for improving cancer-related fatigue and quality of life in breast cancer survivors. Eur J Cancer Care (Engl). 2014 Jan;23(1):15-21. doi: 10.1111/ecc.12114. Epub 2013 Aug 16.</citation>
    <PMID>23947581</PMID>
  </reference>
  <reference>
    <citation>Galanti G, Stefani L, Gensini G. Exercise as a prescription therapy for breast and colon cancer survivors. Int J Gen Med. 2013 Apr 16;6:245-51. doi: 10.2147/IJGM.S42720. Print 2013.</citation>
    <PMID>23620675</PMID>
  </reference>
  <reference>
    <citation>Blanchard CM, Courneya KS, Laing D. Effects of acute exercise on state anxiety in breast cancer survivors. Oncol Nurs Forum. 2001 Nov-Dec;28(10):1617-21.</citation>
    <PMID>11759309</PMID>
  </reference>
  <reference>
    <citation>Byrne A, Byrne DG. The effect of exercise on depression, anxiety and other mood states: a review. J Psychosom Res. 1993 Sep;37(6):565-74. Review.</citation>
    <PMID>8410742</PMID>
  </reference>
  <reference>
    <citation>King AC, Taylor CB, Haskell WL. Effects of differing intensities and formats of 12 months of exercise training on psychological outcomes in older adults. Health Psychol. 1993 Jul;12(4):292-300. Erratum in: Health Psychol 1993 Sep;12(5):405.</citation>
    <PMID>8404803</PMID>
  </reference>
  <reference>
    <citation>Blumenthal JA, Williams RS, Needels TL, Wallace AG. Psychological changes accompany aerobic exercise in healthy middle-aged adults. Psychosom Med. 1982 Dec;44(6):529-36.</citation>
    <PMID>7163456</PMID>
  </reference>
  <reference>
    <citation>Singh NA, Clements KM, Fiatarone MA. A randomized controlled trial of progressive resistance training in depressed elders. J Gerontol A Biol Sci Med Sci. 1997 Jan;52(1):M27-35.</citation>
    <PMID>9008666</PMID>
  </reference>
  <reference>
    <citation>MacVicar MG, Winningham ML, Nickel JL. Effects of aerobic interval training on cancer patients' functional capacity. Nurs Res. 1989 Nov-Dec;38(6):348-51.</citation>
    <PMID>2587289</PMID>
  </reference>
  <reference>
    <citation>Mock V, Frangakis C, Davidson NE, Ropka ME, Pickett M, Poniatowski B, Stewart KJ, Cameron L, Zawacki K, Podewils LJ, Cohen G, McCorkle R. Exercise manages fatigue during breast cancer treatment: a randomized controlled trial. Psychooncology. 2005 Jun;14(6):464-77.</citation>
    <PMID>15484202</PMID>
  </reference>
  <reference>
    <citation>Monga U, Garber SL, Thornby J, Vallbona C, Kerrigan AJ, Monga TN, Zimmermann KP. Exercise prevents fatigue and improves quality of life in prostate cancer patients undergoing radiotherapy. Arch Phys Med Rehabil. 2007 Nov;88(11):1416-22.</citation>
    <PMID>17964881</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 18, 2016</study_first_submitted>
  <study_first_submitted_qc>July 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2016</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Radiation therapy for Breast Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Fatigue</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

